To further build on these findings, we investigated the effects of genetically removing the miR-132/212 cluster in PS19 mice, a model of pure tauopathy that overexpresses human tau with a mutation (P301S) that causes FTD in humans (62). The gene discussed is MAPT; the disease is frontotemporal dementia.